Drug Type Peptides |
Synonyms RBIO-003 |
Target |
Action modulators |
Mechanism ADRA1 modulators(Adrenergic receptor alpha-1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anaphylaxis | Discovery | United States | 01 Oct 2025 |





